A review of atomoxetine effects in young people with developmental disabilities.

This page provides detailed information about this publication. Please click on any text which is underlined to find more information.

Authors: Michael G. Aman, Tristram Smith, L. Eugene Arnold, Patricia Corbett-Dick, Rameshwari V. Tumuluru, Jill A. Hollway, Susan L. Hyman, Marissa Mendoza-Burcham, Xueliang Pan, Daniel W. Mruzek, Luc Lecavalier, Lynne Levato, Laura B. Silverman, Benjamin L. Handen
Title: A review of atomoxetine effects in young people with developmental disabilities.
Journal: Research in Developmental Disabilities
Year: 2014
Month: June
Volume: 35
Issue: 6
Page(s): pp. 1412-1424.
Full Item: Read Full Item (New Window)
Publication Format: Journal Article
Efficacy Study/Review: Yes
Scientific Validity: Peer-Reviewed, Selective/Systematic Review
Keywords: Adolescent / Secondary School Age, Asperger Syndrome, Atomoxetine, Attention/Concentration, Attention Deficit Hyperactivity Disorder, Autism, Autistic Disorder, Child/Children, Developmental Disability/Disorder, Hyperactivity, Intervention, Medication, Pervasive Developmental Disorder (Not Otherwise Specified), Primary / Elementary School Age, Selective Noradrenaline Re-Uptake Inhibitor, Side Effects